Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. - Wikidata - awgldk - TriplyDB

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.

http://www.wikidata.org/entity/Q34029684

about

Vortioxetine for depression in adults Bupropion versus other antidepressive agents for depression Fluoxetine versus other types of pharmacotherapy for depression Citalopram versus other anti-depressive agents for depression Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis A meta-analysis of lipid peroxidation markers in major depression Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis A systematic review of Chinese randomized clinical trials of SSRI treatment of depression Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis The depression treatment cascade in primary care: a public health perspective.What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders Antidepressants and the Placebo Effect The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials.Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Molecular, Functional, and Structural Imaging of Major Depressive Disorder.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Evidence Map of Yoga for Depression, Anxiety, and Posttraumatic Stress Disorder Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism.A systematic approach to pharmacotherapy for geriatric major depression Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.State Investments in Psychiatric Innovation: Investigating Unmeasured State Factors.Efficacy of new generation antidepressants: differences seem illusory Comparing bona fide psychotherapies of depression in adults with two meta-analytical approaches Efficacy comparison of duloxetine and SSRIs at doses approved in Japan.Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.Reduction of patient-reported antidepressant side effects, by type of collaborative care Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomised controlled trials.Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression.From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

P2860

Q24186313-8352D304-B701-4347-A959-BDEE65367CE8 Q24198214-39F31133-FDBF-4A9F-93FD-81C29696B3BB Q24201165-D53D3272-0890-4890-AFDA-6B3F5D6D5AF9 Q24202141-6C2D7557-772F-4695-AE46-7DF2E0024C13 Q26773538-AB43EAE7-1570-4DE8-894B-6F4D230ABF36 Q26778489-C5EC9AD3-D1CD-44C3-BD47-F3DB8E5F9882 Q26779632-5C342E18-464A-41AD-91AB-27403E32C544 Q26829417-89B5BEC0-3778-4665-B1FE-419D5B1F07AD Q27022217-C3B7ED60-B22E-4AE7-8C8D-66B63D7689E6 Q27692061-57956A5E-0500-4253-8D75-394B060346BE Q28080858-0F12650D-52DD-4559-A280-02ECE91AE40D Q28468667-DACA0ADF-44BE-48BA-8D42-DFC05633311E Q28542596-F8569D1E-CAED-478E-818A-8453D706EA2D Q30238926-239E733F-031A-490C-9F58-0BA7EF8AEBF4 Q30373410-C90FD62B-27B1-4BDF-AA8C-276AFC551C09 Q30458935-3AC71BFD-E50D-4EF6-B4D3-71F7989CDD95 Q31090058-D3DD1AF6-11A8-4435-B97D-A8260AC06BC5 Q33718185-32636945-9F52-46BD-8FEA-5D9911324158 Q33764818-3FBC2E49-CB16-415D-A35A-3F98E507285C Q33803327-259016BB-0471-401D-8D6A-FCA645234447 Q34004408-AEDA2006-083E-4C90-A276-C96B00AD337D Q34243328-CB0234CB-B015-430C-B95A-A29B25BD8EEA Q34254323-891DED6C-0A7A-4911-895F-15DE79EF0B54 Q34255703-A8C177BA-76AB-4B65-8733-6E21C26C8B04 Q34355963-7C6D6596-0474-40D4-B5FE-D27FBDBD58F6 Q34386877-460B1E52-13F4-43B7-9B54-D54517DDEF99 Q34471643-31C39605-7181-4F58-82CB-8FBDB0AC533F Q34482769-7E7D8FBD-104D-44A5-8EB2-0786452E1834 Q34765596-D9A93308-698E-412F-BA55-5090C65B09F8 Q34808545-64A896A0-E684-4518-950F-597B1C3F5077 Q34977592-75CF5ABD-A650-4418-9A41-A572D81FB1A4 Q35066804-530921C4-6672-46C7-83F0-F3F14D763E4F Q35162633-AEC0DD7E-A260-4EDA-9C15-814CF1B42664 Q35786992-659100E1-6B45-439F-B02D-9FD42FB0EC3A Q35862776-EE24C1F8-0C29-4700-A9FD-8EB3AFCDBFE0 Q36020033-8CE31266-038C-4C7B-A527-F86402BDD8B0 Q36042111-FE2D6FB5-0FFA-4E78-B0A2-C32650C7A1C4 Q36487328-DE65ABEF-24D7-44D4-91BF-4F238E11E052 Q36551469-96E8459C-B0FC-4F74-87EB-95B08EF007A4 Q36601436-3CC32233-7007-4BE7-B293-863F875A9457

P2860

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.

http://www.wikidata.org/entity/Q34029684

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Comparative benefits and harms ...... der: an updated meta-analysis.

@ast

Comparative benefits and harms ...... der: an updated meta-analysis.

@en

Comparative benefits and harms ...... der: an updated meta-analysis.

@nl

type

label

Comparative benefits and harms ...... der: an updated meta-analysis.

@ast

Comparative benefits and harms ...... der: an updated meta-analysis.

@en

Comparative benefits and harms ...... der: an updated meta-analysis.

@nl

prefLabel

Comparative benefits and harms ...... der: an updated meta-analysis.

@ast

Comparative benefits and harms ...... der: an updated meta-analysis.

@en

Comparative benefits and harms ...... der: an updated meta-analysis.

@nl

P1433

Q34029684-CE8A59A9-E540-40E5-968A-C26D6EAD9B14

P1476

Q34029684-0253C100-5BA4-4E19-86A9-0EED35784F46

P2093

Q34029684-19D91343-6330-4F54-B537-8AA38734649D

Q34029684-22566F98-2F2D-4386-8390-15FAE8523FF1

Q34029684-42862B56-E4DA-458B-BEA4-142089882422

Q34029684-433B66F2-C06C-4ECD-8116-5940FC39CCCC

Q34029684-49F4333E-6DFE-470F-B6DB-7C24FFF39A1B

Q34029684-93806121-B00F-47E2-83F9-AE8727412FE9

Q34029684-9EC0A2D9-04A9-490C-A188-4A60444BC7D0

Q34029684-9FFE3205-D13F-4B77-963C-8E79574EE985

Q34029684-B50172B3-AFA3-4F8C-88AE-373471672F66

Q34029684-BAB9B2EF-E846-4280-9508-4CBC1747957C

P304

Q34029684-2405294F-85B8-406E-919E-6FA9FE51E038

P31

Q34029684-DB0C4C94-588F-4F53-A271-00E6A518FFE4

Q34029684-fe72f635-af7a-47d9-8190-cf7be349ba6b

P356

Q34029684-9C9ED959-DEEA-4747-A3FF-F42FBF0E6603

P407

Q34029684-9714F0CD-B30B-4C96-82F0-0D3809FEE84C

P433

Q34029684-BDC55BE3-B5D1-4DC0-BB0E-F7F6E88B5B6B

P478

Q34029684-4F790E4B-C5C6-4934-A788-7FD1F99120D4

P50

Q34029684-3716A798-5116-40D0-B9AD-873D4365204E

Q34029684-96126949-9A02-4CB6-B0A7-F9FDD1F31DEA

P577

Q34029684-AB99264D-1E13-4360-B2FC-4739C90C06DB

P698

Q34029684-FB0081D6-6D33-4912-B2C9-7563E03D703F

P921

Q34029684-A5D27B7D-38CD-4BF7-92BF-130638070ADA

P356

0003-4819-155-11-201112060-00009

P1433

Annals of Internal Medicine

P1476

Comparative benefits and harms ...... der: an updated meta-analysis.

@en

P2093

Bradley N Gaynes

http://www.w3.org/2001/XMLSchema#string

Kathleen N Lohr

http://www.w3.org/2001/XMLSchema#string

Kylie Thaler

http://www.w3.org/2001/XMLSchema#string

Laura C Morgan

http://www.w3.org/2001/XMLSchema#string

Linda Lux

http://www.w3.org/2001/XMLSchema#string

Michaela Strobelberger

http://www.w3.org/2001/XMLSchema#string

Patricia Thieda

http://www.w3.org/2001/XMLSchema#string

Richard A Hansen

http://www.w3.org/2001/XMLSchema#string

Stacey Lloyd

http://www.w3.org/2001/XMLSchema#string

Tania Wilkins

http://www.w3.org/2001/XMLSchema#string

P304

772-785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-155-11-201112060-00009

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P50

Gerald Gartlehner

Megan Van Noord

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22147715

http://www.w3.org/2001/XMLSchema#string

P921